| mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.004 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
| mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.006 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.006 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.006 |
| mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.006 |
| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.007 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.008 |